Logiscreen

Staar Surgical Company

$29.99
Market Cap 1.48B
ROE -6.1%
Gross Margin 73.6%
Debt/Equity 0.1
Current Ratio 5.1
Revenue QoQ 119.6%
EPS QoQ -1.1%
F-Score 3

About

STAAR Surgical is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic surgery, and for 30 years, STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer® Lenses (ICLs), using its proprietary biocompatible Collamer material. STAAR ICL’s are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye’s natural crystalline lens. Its EVO ICL™ product line provides visual freedom through a quick, minimally invasive procedure. STAAR has sold more than 3 million ICLs in over 75 countries. Headquartered in Lake Forest, California, the company operates research, development, manufacturing, and packaging facilities in California and Switzerland.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-70.30
vs median 33.61
P/B
4.20
vs median 2.16
ROE
-0.06
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics